Institute Of Advanced Medical Studies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 M
- Revenue Growth %
- Profit Growth 13.25%
- Net Worth -20.15%
- Total Assets -5.58%
About Institute Of Advanced Medical Studies
Institute Of Advanced Medical Studies Private Limited (IOAMSPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 July 2005 and has a history of 19 years and six months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.50 M.
Sukrit Sharma and Naman Sharma serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U80903GJ2005PTC046504
- Company No.
046504
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jul 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Institute Of Advanced Medical Studies?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sukrit Sharma | Managing Director | 28-Jul-2005 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Naman Sharma | Director | 21-Feb-2009 | Current |
Financial Performance of Institute Of Advanced Medical Studies.
Institute Of Advanced Medical Studies Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 13.25% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
What is the Ownership and Shareholding Structure of Institute Of Advanced Medical Studies?
In 2021, Institute Of Advanced Medical Studies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.50 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.45 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
21 Feb 2014 | Indian Overseas Bank | ₹4.50 M | Open |
How Many Employees Work at Institute Of Advanced Medical Studies?
Unlock and access historical data on people associated with Institute Of Advanced Medical Studies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Institute Of Advanced Medical Studies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Institute Of Advanced Medical Studies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.